Browse studies, page 889
Page 889 of 1,287, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- A phase 2, randomized, double-blind, double-dummy, placebo-controlled, dose-ranging, dose-finding, parallel group study to assess efficacy and safety of PF-06865571 (DGAT2I) alone and when coadministered with PF-05221304 (acci) in adult participants with biopsy-confirmed nonalcoholic steatohepatitis and fibrosis stage 2 or 3 ClinicalTrials.gov · COMPLETED, 2024
- The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction - A Feasibility Study ClinicalTrials.gov · TERMINATED, 2024
- Wellness and Epigenetic Impact of a Natural Product Supplement System Combined With Lifestyle Modification ClinicalTrials.gov · COMPLETED, 2025
- A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years ClinicalTrials.gov · COMPLETED, 2015
- Low Level Laser Therapy for the Treatment of Provoked Vestibulodynia ClinicalTrials.gov · TERMINATED, 2013
- Eyelid Warming Technology for Relief of Meibomian Gland Dysfunction in an Asian Population ClinicalTrials.gov · COMPLETED, 2013
- Effect of Arginase Inhibition on Microvascular Endothelial Function in Patients With Type 2 Diabetes and Microvascular Dysfunction ClinicalTrials.gov · COMPLETED, 2016
- A Randomized, Multicenter, Double-Masked, Placebo Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease ClinicalTrials.gov · COMPLETED, 2021
- Pilot Study Evaluating the Efficacy, Tolerance and Safety of VITAL AF (Semi Elemental, High Protein, High Omega 3 Fat Enteral Formula) Versus Osmolite 1.2 (High Protein Enteral Formula) in Multiple ICU Settings (Medical, Surgical, Cardiothoracic) ClinicalTrials.gov · COMPLETED, 2014
- Is Oxidative Stress in Semen Reduced by Lifestyle Intervention ClinicalTrials.gov · COMPLETED, 2020
- COLSIO Trial: Phase II Randomized, Controlled Trial of Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity ClinicalTrials.gov · COMPLETED, 2025
- A phase 2A, randomized, double-blind, placebo-controlled, parallel-group study of CE-224,535, an antagonist of the P2X7 receptor, in the treatment of the signs and symptoms of rheumatoid arthritis in subjects WHO are inadequately controlled on methotrexate ClinicalTrials.gov · COMPLETED, 2009
- Intermittent Fasting Monitoring for Human Optimization Utilizing Wearable Technology: an N-of-1 Prospective Study ClinicalTrials.gov · COMPLETED, 2025
- An Open Label Pilot Study to Evaluate the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 in Healthy Subjects and Subjects on Statins ClinicalTrials.gov · COMPLETED, 2015
- A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen ClinicalTrials.gov · COMPLETED, 2016
- Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older ClinicalTrials.gov · COMPLETED, 2014
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis of the Face or Balding Scalp ClinicalTrials.gov · COMPLETED, 2013
- Effect of a Community Service-Learning Intervention on Medical Empathy and Perceived Clinical Self-Efficacy in Fourth-Semester Medical Students at FES Iztacala, UNAM: A Quasi-Experimental Pre-Post Study ClinicalTrials.gov · COMPLETED, 2026
- A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI) ClinicalTrials.gov · COMPLETED, 2022
- Prevention of Aromatase Inhibitor-Induced Joint Symptoms With Omega 3 Fatty Acid Supplementation: a Randomized Placebo Controlled Pilot Study ClinicalTrials.gov · COMPLETED, 2014
- A Double Blind, Randomized Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome ClinicalTrials.gov · COMPLETED, 2015
- A Phase II Randomised, Double-blind, Parallel-group, Multicentre, International Trial to Investigate the Safety and Efficacy of Vicadrostat and Empagliflozin Administered With Simultaneous vs Staggered Initiation in Participants With Chronic Kidney Disease at Risk of Kidney Disease Progression ClinicalTrials.gov · COMPLETED, 2026
- Supplementation of Omega-3 Fatty Acid Complex to Routine Statin Treatment Decreases Patients' Day-time Blood Pressure, Improves Inflammatory Status and Prohibits Platelet Aggregation ClinicalTrials.gov · COMPLETED, 2008
- A Phase 1b/2a Multicenter Study to Assess the Safety and Tolerability, Pharmacokinetics, and Preliminary Efficacy of KPG-818 in Patients With Systemic Lupus Erythematosus ClinicalTrials.gov · COMPLETED, 2023
- The Effect of Nutritional Interventions on Exercise-induced Muscle Damage ClinicalTrials.gov · COMPLETED, 2017
- Transfusion of Autologous Umbilical Cord Blood Plus Vitamin D and Omega 3 Fatty Acids to Preserve Beta Cell Function in Children With Recent Onset Type 1 Diabetes - A Pilot Study ClinicalTrials.gov · COMPLETED, 2012
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis ClinicalTrials.gov · COMPLETED, 2021
- Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters ClinicalTrials.gov · COMPLETED, 2013
- A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications ClinicalTrials.gov · TERMINATED, 2020
- Secondary Prevention of Atrial Fibrillation With an Alpha-Linolenic Enriched Diet : a Randomized Study ClinicalTrials.gov · COMPLETED, 2003
- Effects of the Supplementation With Omega 3 Fatty Acids in Patients With Chronic Renal Disease ClinicalTrials.gov · COMPLETED, 2018
- Protocol for a Randomized, Placebo-Controlled, Double-Blinded Trial to Study the Effects of Supplementary Omega-3 Fatty Acids on Serum C-Reactive Protein Levels ClinicalTrials.gov · TERMINATED, 2007
- The Effect of Short Term Omega-3 Supplementation on Exercise Performance and Neuromuscular Function ClinicalTrials.gov · COMPLETED, 2014
- Effects of Ultramicronized Palmitoylethanolamide on Smell, Taste, and Sensory Sensitivity in Children With Autism Spectrum Disorder ClinicalTrials.gov · COMPLETED, 2025
- Effectiveness of Two Different Forms of Marine Oil, Derived From the New Zealand Green Lipped Mussel and Krill Oil, on Indirect Markers of Muscle Damage and Soreness During Recovery From Muscle Damaging Exercise in Untrained Men ClinicalTrials.gov · COMPLETED, 2019
- Blockade of Vascular Potassium Channels During Human Endotoxemia ClinicalTrials.gov · COMPLETED, 2005
- Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses ClinicalTrials.gov · COMPLETED, 2024
- A Dietary Approach to Reduce the Frequency of Relapse in Ulcerative Colitis Patients: a Randomized Controlled Clinical Trial Study ClinicalTrials.gov · COMPLETED, 2017
- The Effects of Purified n-3 Fatty Acids on Serum Fibrosis Markers and Cardiovascular Risk Markers in a Randomized Placebo Controlled Trial in Patients With Non Alcoholic Fatty Liver Disease ClinicalTrials.gov · COMPLETED, 2018
- Oral Mucosal Escalation Goal Assessment (OMEGA) Study: A Randomized Placebo-Controlled Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut ClinicalTrials.gov · COMPLETED, 2023
- Impact of Immunomodulating Oral Nutrition on Surgical Complications ClinicalTrials.gov · COMPLETED, 2025
- Dietary Intervention Increasing Omega-3 Intake- Feasibility Trial ClinicalTrials.gov · COMPLETED, 2020
- A Randomised, Double-blind, Placebo Controlled Study to Investigate the Effect on Knee Pain Reduction and Safety of Swisse High Strength Deep Sea Krill Oil (Superba BOOST) in Adults With Mild to Moderate Osteoarthritis of the Knee ClinicalTrials.gov · COMPLETED, 2019
- A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extension Periods of 90 and 180 Days ClinicalTrials.gov · COMPLETED, 2013
- Randomized Controlled Trial of Oxybutynin and Omega-3 Fatty Acid Supplementation Versus Oxybutynin and Placebo for Treatment of Overactive Bladder in Women ClinicalTrials.gov · TERMINATED, 2015
- Effet d'Une supplémentation Par OMEGA3 Dans la rétinopathie diabétique ClinicalTrials.gov · COMPLETED, 2025
- EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2020
- A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Long-term Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events ClinicalTrials.gov · COMPLETED, 2017
- A Randomized, Multi-center, Cross-over, Comparative Bioavailability Study of DOXIL/CAELYX Manufactured at a New Site in Patients With Advanced or Refractory Ovarian or Breast Cancer ClinicalTrials.gov · COMPLETED, 2024
- Essential Fatty Acid Nutrition in Infants 1 to 2 Years-of-Age ClinicalTrials.gov · COMPLETED, 2016
- OMEGA: A Prospective, Randomised, Double-Blind, Placebo-Controlled Multicentre Study in Patients Who Survived Acute Myocardial Infarction to Investigate the Efficacy and Safety of 1 Gram Ω-3-Fatty Acid Ethyl Esters (Ω-3FAE) Daily Versus Placebo to Reduce the Risk of Sudden Cardiac Death ClinicalTrials.gov · COMPLETED, 2008
- Omega-3 Fatty Acid Supplementation to Enhance Performance in Collegiate Athletes ClinicalTrials.gov · COMPLETED, 2023
- A Placebo Controlled Double Blinded Prospective Study to Investigate the Usefulness of Omega 3 Fatty Acids in the Relief of Vasomotor Symptoms of Menopausal Women ClinicalTrials.gov · COMPLETED, 2009
- A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy and an Open-labeled Long-term Safety Extension Treatment With Seltorexant ClinicalTrials.gov · COMPLETED, 2024
- A phase 1, open-label study to evaluate the pharmacokinetics, safety, and tolerability of orally administered nirmatrelvir/ritonavir in pregnant women with mild-to-moderate COVID-19 ClinicalTrials.gov · TERMINATED, 2025
- A Nutritional and Social Skills Intervention on Conduct Disorder and Hyperactivity ClinicalTrials.gov · COMPLETED, 2014
- A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee ClinicalTrials.gov · COMPLETED, 2017
- Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities ClinicalTrials.gov · COMPLETED, 2015
- Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial ClinicalTrials.gov · COMPLETED, 2010
- A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double--Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels ≥500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment ClinicalTrials.gov · COMPLETED, 2019
- An International, Double Blind, Randomized, Phase III Study to Evaluate the Tolerance, Safety, and Effectiveness of Viramune (Nevirapine) in Preventing Clinical AIDS Progression Events or Death When Used in Combination With Lamivudine (3TC) and Stable (>= 4 Weeks) Background Nucleoside Therapy ClinicalTrials.gov · COMPLETED
- Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) and Prospective, Randomized, Blinded, Placebo-Controlled, Multi-Center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) ClinicalTrials.gov · TERMINATED, 2009
- A Randomized, Double-blinded, Cross-over Study on the Use of Ritmonutra, a Nutraceutical Product Composed of Omega 3 Fatty Acids, Astaxanthin, Vitamin E and Hawthorn in Subjects Affected by Supraventricular Ectopic Beats Without Structural Heart Disease ClinicalTrials.gov · TERMINATED, 2014
- Pilot Study "Health Promoting Effects of the Microalgae Phaeodactylum Tricornutum" ClinicalTrials.gov · COMPLETED, 2020
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy ClinicalTrials.gov · COMPLETED, 2021
- A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Add-On Therapy With Saxagliptin and Dapagliflozin Added to Metformin Compared to Add-On Therapy With Saxagliptin in Combination With Metformin or Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone ClinicalTrials.gov · COMPLETED, 2014
- The Effect of Omega-3 Fatty Acids on Hypertriglyceridemia in Patients With Type 2 Diabetes Mellitus ClinicalTrials.gov · COMPLETED, 2021
- Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial (Acronym: DO-HEALTH) ClinicalTrials.gov · COMPLETED, 2018
- The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain ClinicalTrials.gov · COMPLETED, 2017
- Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With Coronary Artery Disease ClinicalTrials.gov · COMPLETED, 2013
- A Phase II, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus ClinicalTrials.gov · COMPLETED, 2019
- Epithelial Healing and Visual Outcomes of Patients Using Omega-3 Supplements as an Adjunct Therapy Before and After Photorefractive Keratectomy (PRK) Surgery ClinicalTrials.gov · COMPLETED, 2011
- "Go Fish"Omega-3 Fatty Acid Supplementation in Diabetic Kidney Disease ClinicalTrials.gov · COMPLETED, 2011
- Preoperative Intravenous Omega 3 Fatty Acids Administration in Valvular Surgery Patients: A Prospective, Randomized, Open-label, Comparative Clinical Trial ClinicalTrials.gov · COMPLETED, 2010
- Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye ClinicalTrials.gov · COMPLETED, 2018
- Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair ClinicalTrials.gov · COMPLETED, 2018
- The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease ClinicalTrials.gov · COMPLETED, 2015
- A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Postmenopausal Women With Estrogen Receptor Positive Breast Cancer ClinicalTrials.gov · COMPLETED, 2020
- A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD ClinicalTrials.gov · COMPLETED, 2026
- Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back ClinicalTrials.gov · COMPLETED, 2009
- A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders ClinicalTrials.gov · COMPLETED, 2015
- A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D With NovoLog® in Type 1 Diabetes Mellitus Patients ClinicalTrials.gov · COMPLETED, 2020
- Beyond Benefits of Q10: Mitochondrial Cocktail for Gulf War Illness ClinicalTrials.gov · COMPLETED, 2023
- The Effect of a New Newborn Formula Over the Corporal Composition: a Randomized Multicentric Clinical Trial ClinicalTrials.gov · COMPLETED, 2020
- The Impact of Pastured Livestock Food Consumption on Fatty Acid and Metabolomic Profiles ClinicalTrials.gov · COMPLETED, 2025
- The Effect of Acute and Short-term Intervention With Fish Oil on Overweight Subjects - Focus on Inflammation ClinicalTrials.gov · COMPLETED, 2009
- Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review Nutritional neuroscience, 2019
- Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action Molecular Aspects of Medicine, 2018
- Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women Scientific Reports, 2017
- Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease Cochrane Database of Systematic Reviews, 2019
- Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation Open Heart, 2018
- The Effect of Omega-3 Fatty Acids on Rheumatoid Arthritis Mediterranean Journal of Rheumatology, 2020
- Emerging Class of Omega-3 Fatty Acid Endocannabinoids & Their Derivatives Prostaglandins & other lipid mediators, 2019
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks JAMA cardiology, 2018
- Effect of diet lipids and omega-6:3 ratio on honey bee brood development, adult survival and body composition Journal of insect physiology, 2020
- Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6/omega-3 ratio in children. A randomized, double-blind and controlled trial Psychiatry Research, 2020
- A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia Nutrients, 2019
- Omega 3-metabolism, absorption, bioavailability and health benefits–A review 2019
- Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress Nutrients, 2018
- Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology, 2013